Stocktwits on MSN1d
J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient
Shares of Johnson & Johnson fell over 2% on Wednesday, hitting nearly one-week lows, despite reporting better-than-expected ...
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical ...
Hosted on MSN19h
J.J. McCarthy Shows Off New Haircut
The Minnesota Vikings’ season ended in a heartbreaking fashion. However, if there’s a silver lining, it is that the J.J.
Vikings Get Concerning Assessment on Quarterback J.J. McCarthy
Minnesota Vikings QB J.J. McCarthy is a relative unknown and suffered a serious knee injury, which has led to questions ...
J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short
Johnson & Johnson posted its fourth-quarter earnings report Wednesday morning, with adjusted profits beating expectations ...
J&J Reports Strong Revenue and Profit but Faces Challenges in 2025
Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. But shares slipped 3.2% to $143.35 in Wednesday morning trading, ...
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...